Drugs / L-asparaginases
last change Jun 2026 re-read 2 minutes ago

L-asparaginases

Developed for
secondary hemophagocytic lymphohistiocytosis
Investigated by
Beijing Friendship Hospital

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05315336 Jun 2022 → Jun 2025 secondary hemophagocytic lymphohistiocytosis Beijing Friendship Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as L-asparaginases L-asparaginases 6000iu/m2 day2, day4” NCT05315336